ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

GOSS vs XBIT // OPTIONS IMPLIED MOVE & PUT/CALL SKEW

Gossamer Bio Inc. (NASDAQ) VS. XBiotech Inc. (NASDAQ) • 15-METRIC TALLY: GOSS 1 — XBIT 2
■ METRIC PARITY
options-implied-move
—
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (GOSS VS. XBIT) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC GOSS XBIT SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin -60.00% — — TIE /operating-margins <GO>
Net Profit Margin -60.00% — — TIE /net-margins <GO>
Revenue Growth (YoY) -57.70% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 1/9 2/9 -1.00 XBIT /piotroski-score <GO>
Options Implied Move & Put/Call Skew ACTIVE — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 43.5 38.6 +4.90 GOSS /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $57.8M $58.5M -$736.5K XBIT /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR GOSS REV XBIT REV GOSS GROSS % XBIT GROSS % GOSS FCF XBIT FCF
FY 2025 $48.5M $155.9M — — -$171.3M -$40.2M
FY 2024 $114.7M $118.9M — — -$3.5M -$32.3M
FY 2023 $514.5M $105.0M — — -$159.2M -$18.7M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
GOSS // BETA —
XBIT // BETA —